| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |